Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 60

1.

An efficient algorithm to perform local concerted movements of a chain molecule.

Zamuner S, Rodriguez A, Seno F, Trovato A.

PLoS One. 2015 Mar 31;10(3):e0118342. doi: 10.1371/journal.pone.0118342. eCollection 2015.

2.

Population modelling of patient responses in antidepressant studies: a stochastic approach.

Marostica E, Russu A, Gomeni R, Zamuner S, De Nicolao G.

Math Biosci. 2015 Mar;261:37-47. doi: 10.1016/j.mbs.2014.11.007. Epub 2014 Dec 4.

PMID:
25481225
3.

Continuous-time Markov modelling of flexible-dose depression trials.

Marostica E, Russu A, Gomeni R, Zamuner S, De Nicolao G.

J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):625-38. doi: 10.1007/s10928-014-9389-6. Epub 2014 Oct 4.

PMID:
25281421
4.

Photobiostimulation reduces edema formation induced in mice by Lys-49 phospholipases A2 isolated from Bothrops moojeni venom.

Nadur-Andrade N, Dale CS, Santos AS, Soares AM, de Lima CJ, Zamuner SR.

Photochem Photobiol Sci. 2014 Nov;13(11):1561-7. doi: 10.1039/c4pp00111g.

PMID:
25232894
5.

Population model of longitudinal FEV1 data in asthmatics: meta-analysis and predictability of placebo response.

Marostica E, Russu A, Yang S, De Nicolao G, Zamuner S, Beerahee M.

J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):553-69. doi: 10.1007/s10928-014-9373-1. Epub 2014 Aug 15.

PMID:
25123552
6.

Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach.

Inamdar A, Merlo-Pich E, Gee M, Makumi C, Mistry P, Robertson J, Steinberg E, Zamuner S, Learned S, Alexander R, Ratti E.

J Psychopharmacol. 2014 Apr 2;28(6):570-581. [Epub ahead of print]

PMID:
24699061
7.

Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomnia.

Ratti E, Carpenter DJ, Zamuner S, Fernandes S, Squassante L, Danker-Hopfe H, Archer G, Robertson J, Alexander R, Trist DG, Merlo-Pich E.

Sleep. 2013 Dec 1;36(12):1823-30. doi: 10.5665/sleep.3208.

8.

Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials.

Choy EH, Bendit M, McAleer D, Liu F, Feeney M, Brett S, Zamuner S, Campanile A, Toso J.

Arthritis Res Ther. 2013 Sep 24;15(5):R132. doi: 10.1186/ar4312.

9.

Analgesic Effect of Light-Emitting Diode (LED) Therapy at Wavelengths of 635 and 945 nm on Bothrops moojeni Venom-Induced Hyperalgesia.

Nadur-Andrade N, Zamuner SR, Toniolo EF, de Lima CJ, Cogo JC, Dale CS.

Photochem Photobiol. 2013 Oct 17. doi: 10.1111/php.12189. [Epub ahead of print]

PMID:
24131406
10.

Protective effect of low-level laser therapy (LLLT) on acute zymosan-induced arthritis.

Carlos FP, de Paula Alves da Silva M, de Lemos Vasconcelos Silva Melo E, Costa MS, Zamuner SR.

Lasers Med Sci. 2014 Mar;29(2):757-63. doi: 10.1007/s10103-013-1413-3. Epub 2013 Aug 10.

PMID:
23933663
11.

Photodynamic inactivation of yeast and bacteria by extracts of Alternanthera brasiliana.

Andreazza NL, de Lourenco CC, Siqueira CA, Sawaya AC, Lapinski TF, Gasparetto A, Khouri S, Zamuner SR, Munin E, Salvador MJ.

Curr Drug Targets. 2013 Aug;14(9):1015-22.

PMID:
23547779
12.

Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies.

Ratti E, Bettica P, Alexander R, Archer G, Carpenter D, Evoniuk G, Gomeni R, Lawson E, Lopez M, Millns H, Rabiner EA, Trist D, Trower M, Zamuner S, Krishnan R, Fava M.

J Psychopharmacol. 2013 May;27(5):424-34. doi: 10.1177/0269881113480990. Epub 2013 Mar 28.

PMID:
23539641
13.

Non linear mixed effects analysis in PET PK-receptor occupancy studies.

Berges A, Cunningham VJ, Gunn RN, Zamuner S.

Neuroimage. 2013 Aug 1;76:155-66. doi: 10.1016/j.neuroimage.2013.03.006. Epub 2013 Mar 18.

PMID:
23518008
14.

A PCA approach to population analysis: with application to a Phase II depression trial.

Marostica E, Russu A, Gomeni R, Zamuner S, De Nicolao G.

J Pharmacokinet Pharmacodyn. 2013 Apr;40(2):213-27. doi: 10.1007/s10928-013-9304-6. Epub 2013 Mar 17.

PMID:
23504512
15.

A non-linear mixed effect modelling approach for metabolite correction of the arterial input function in PET studies.

Veronese M, Gunn RN, Zamuner S, Bertoldo A.

Neuroimage. 2013 Feb 1;66:611-22. doi: 10.1016/j.neuroimage.2012.10.048. Epub 2012 Oct 27.

PMID:
23108277
16.

The orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomnia.

Bettica P, Squassante L, Zamuner S, Nucci G, Danker-Hopfe H, Ratti E.

Sleep. 2012 Aug 1;35(8):1097-104. doi: 10.5665/sleep.1996.

17.

Joint modeling of efficacy, dropout, and tolerability in flexible-dose trials: a case study in depression.

Russu A, Marostica E, De Nicolao G, Hooker AC, Poggesi I, Gomeni R, Zamuner S.

Clin Pharmacol Ther. 2012 May;91(5):863-71. doi: 10.1038/clpt.2011.322.

PMID:
22472989
18.

Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials.

Learned S, Graff O, Roychowdhury S, Moate R, Krishnan KR, Archer G, Modell JG, Alexander R, Zamuner S, Lavergne A, Evoniuk G, Ratti E.

J Psychopharmacol. 2012 May;26(5):653-62. doi: 10.1177/0269881111424931. Epub 2011 Nov 2.

PMID:
22048884
19.

Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder.

Ratti E, Bellew K, Bettica P, Bryson H, Zamuner S, Archer G, Squassante L, Bye A, Trist D, Krishnan KR, Fernandes S.

J Clin Psychopharmacol. 2011 Dec;31(6):727-33. doi: 10.1097/JCP.0b013e31823608ca. Erratum in: J Clin Psychopharmacol. 2012 Apr;32(2):185.

PMID:
22020354
20.

A pharmacokinetic PET study of NK₁ receptor occupancy.

Zamuner S, Rabiner EA, Fernandes SA, Bani M, Gunn RN, Gomeni R, Ratti E, Cunningham VJ.

Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):226-35. doi: 10.1007/s00259-011-1954-2. Epub 2011 Oct 13.

PMID:
21993526
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk